MSB 7.69% $1.19 mesoblast limited

shocking!!

  1. 1,363 Posts.
    lightbulb Created with Sketch. 116
    This is crap. At last year Regen Med conference, I think it was last year, the co founder Michael Schuster, talked about the pipeline and also clearly stated that 2013 would be a significant news flow year. It's close to September now. And we have not had news of any significantly, 1. Interim disk result. This coupled with the fact that its 2 years now and nothing on CHF phase 3. Must be insignificant to Teva, what a load of crap how can something that has a multiple billion dollar potential not be a priority, actually forget the word priority, that word should not even be considered, a thought in Teva's pipeline. WHAT'S GOING ON????

    Those blasting me for the same opinion 6 months ago are a little silent these days.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.